Top

Reactions Weekly

Published in:

01-06-2023 | Omalizumab | Case report

Itraconazole/omalizumab/prednisolone

Skin rashes, worsening dyspnoea and lack of efficacy: case report

Published in: Reactions Weekly | Issue 1/2023

Excerpt

Author Information

An event is serious (based on the ICH definition) when the patient outcome is&colon;

* death
* life-threatening
* hospitalisation
* disability
* congenital anomaly
* other medically important event

…

Alaga A, et al. Rapid onset of effect of benralizumab in a severe eosinophilic and allergic asthma patient with allergic bronchopulmonary aspergillosis. Respirology Case Reports 11: 1-4, No. 6, 25 May 2023. Available from: URL: http://doi.org/10.1002/rcr2.1167

Title: Itraconazole/omalizumab/prednisolone
Skin rashes, worsening dyspnoea and lack of efficacy: case report
Publication date: 01-06-2023
Publisher: Springer International Publishing
Keywords: Omalizumab
Itraconazole
Aspergillosis
Bronchial Asthma
Prednisolone
Published in: Reactions Weekly / Issue 1/2023
Print ISSN: 0114-9954
Electronic ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-41900-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Itraconazole/omalizumab/prednisolone

Skin rashes, worsening dyspnoea and lack of efficacy: case report

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2023

Antineoplastic drugs

Apixaban/enoxaparin-sodium/lenalidomide

Tozinameran/warfarin

Multiple drugs

Convalescent-anti-sars-cov-2-plasma/immune-globulin

Prednisone/thalidomide